BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6865972)

  • 1. Monoamine oxidase activity in platelets before and after sleep deprivation as predictor for antidepressive drug response.
    Fähndrich E; Müller-Oerlinghausen B
    Mod Probl Pharmacopsychiatry; 1983; 19():327-36. PubMed ID: 6865972
    [No Abstract]   [Full Text] [Related]  

  • 2. [When do I give which antidepressant in the individual case?].
    Fähndrich E
    Nervenarzt; 1984 Sep; 55(9):477-82. PubMed ID: 6504224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
    Fähndrich E
    Pharmacopsychiatria; 1983 Nov; 16(6):179-85. PubMed ID: 6665027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions.
    Georgotas A; Mann J; Friedman E
    Biol Psychiatry; 1981 Oct; 16(10):997-1001. PubMed ID: 7306621
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological predictors of success of antidepressant drug therapy.
    Fähndrich E
    Psychiatr Dev; 1987; 5(2):151-71. PubMed ID: 3628243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of therapy-refractory depressions].
    Pöldinger W; Alac S; Krebs-Roubicek E
    Act Nerv Super (Praha); 1982 May; 24(2):55-62. PubMed ID: 6125075
    [No Abstract]   [Full Text] [Related]  

  • 7. [EEG sleep patterns and biogenic amine metabolizing enzymes in patients with endogenous depression].
    Nowicki Z; Gałuszko P; Landowski J
    Psychiatr Pol; 1991; 25(3-4):1-3. PubMed ID: 1821968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sleep deprivation as a predictor of treatment response to antidepressant medication.
    Fähndrich E
    Acta Psychiatr Scand; 1983 Nov; 68(5):341-4. PubMed ID: 6650211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of isocarboxazid on platelet MAO activity.
    Davidson J; White H
    Biol Psychiatry; 1983 Sep; 18(9):1075-9. PubMed ID: 6640004
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypicality in primary depressive illness: a preliminary survey.
    Silberman EK; Post RM
    Biol Psychiatry; 1982 Mar; 17(3):285-304. PubMed ID: 6805520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood platelet MAO activity in endogenous depressive syndrome].
    Puzyński S; Hauptmann M; Załuska M
    Psychiatr Pol; 1980; 14(6):575-80. PubMed ID: 7232599
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. I. Platelet monoamine oxidase (MAO) activity].
    Matsumoto H; Pietruszewska I; Roguska E
    Psychiatr Pol; 1983; 17(1):7-11. PubMed ID: 6622594
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kinetics of blood platelet monoamine oxidase in patients with cyclophrenic depressive syndromes].
    Landowski J
    Psychiatr Pol; 1977; 11(2):151-7. PubMed ID: 887673
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychophysiological characteristics and metabolic indices of neurotransmitter metabolism in patients ill with endogenous depression.
    Wójcik M; Bidziński A; Slósarska M; Puzyński S
    Psychiatr Pol; 1994; 28(3 Suppl):61-71. PubMed ID: 7916466
    [No Abstract]   [Full Text] [Related]  

  • 16. Bulimia and monoamine oxidase inhibitors: a predictor study.
    Hardy BW; Waller DA; Orsulak PJ
    Tex Med; 1985 Oct; 81(10):39-42. PubMed ID: 3904070
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physiological status of the body and prediction of the effectiveness of drug therapy of depression. II. Physiological indicators of the reaction to sleep deprivation].
    Slusarska M; Wójcik M
    Psychiatr Pol; 1991; 25(3-4):38-43. PubMed ID: 1821975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet monoamine oxidase activity and clomipramine-induced mania in unipolar depressed patients.
    van Kammen DP; van Scheyen JD; Murphy DL
    Biol Psychiatry; 1980 Aug; 15(4):565-73. PubMed ID: 7397287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter.
    Müller DJ; Schulze TG; Macciardi F; Ohlraun S; Gross MM; Scherk H; Neidt H; Syagailo YV; Grässle M; Nöthen MM; Maier W; Lesch KP; Rietschel M
    Pharmacopsychiatry; 2002 Jul; 35(4):157-8. PubMed ID: 12163988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.